IL-39 and IL-35 gingival crevicular fluid levels in diabetic patients with generalized periodontitis

被引:0
作者
Sandy shabaan Hassan
Maha Abdelkawy
Olfat Gamil Shaker
Nayroz Abdel Fattah Tarrad
机构
[1] Fayoum University,Oral Medicine and Periodontology Department, Faculty of Dentistry
[2] Ahram Canadian University,Oral Medicine and Periodontology Department, Faculty of Dentistry
[3] Beni-Suef University,Medical Biochemistry and Molecular Biology Department, Faculty of Medicine
[4] Cairo University,undefined
来源
Clinical Oral Investigations | / 28卷
关键词
Periodontitis; Diabetes mellitus; IL-35.IL-39; Non-surgical periodontal therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 217 条
[1]  
Hajishengallis G(2021)Polymicrobial communities in periodontal disease: their quasi-organismal nature and dialogue with the host Periodontol 2000 86 210-230
[2]  
Lamont RJ(2018)Association of human interleukin-35 level in gingival crevicular fluid and serum in periodontal health, disease, and after non-surgical therapy: a comparative study Contemp Clin Dent 9 293-297
[3]  
Raj SC(2000)(2022) Periodontitis and implant complications in diabetes Periodontol 90 88-105
[4]  
Panda SM(2023)The bidirectional relationship between periodontal disease and diabetes mellitus—a review Diagnostics 13 68-7218
[5]  
Dash M(2022)Evaluation of IL-23p19/Ebi3 (IL-39) gingival crevicular fluid levels in periodontal health, gingivitis, and periodontitis Clin Oral Inves 26 7209-512
[6]  
Patnaik K(2015)Interleukin-35: expanding its job profile J Interf Cytokine Res Off J Int Soc Interf Cytokine Res 35 499-707
[7]  
Mohanty D(2017)Role of anti-inflammatory cytokines IL-35 and IL-37 in asthma Inflammation 40 697-20
[8]  
Katti N(2019)Interleukin-35 in immune-related diseases: protection or destruction Immunology 157 13-568
[9]  
Nibali L(2015)Interleukin-12: functional activities and implications for disease Cytokine Growth Factor Rev 26 559-426
[10]  
Gkranias N(2017)Elevated serum IL-39 in patients with ST-segment elevation myocardial infarction was related with left ventricular systolic dysfunction Biomark Med 11 419-217